Summary

Point of Care Testing Market By Product Type (Infectious Diseases Testing, Blood Glucose Monitoring, Cardiac Testing, Coagulation Testing, Fertility Testing, Drug Abuse Testing, Respiratory Testing, Others), By Sample Type (Blood Samples, Respiratory Samples, Urine Samples, Saliva Samples, Fecal Samples, Tissue Samples, Other) and By Technology (Immunoassays, Molecular Diagnostics, Electrochemical Detection, Optical Detection, Bio Sensors, Microfluidics, Imaging Technology, Wearable Technology, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 ? 2035
The Point of Care Testing Market accounted for USD 42.8 billion in 2024 and is expected to reach USD 82.1 billion by 2035, growing at a CAGR of around 6.1% between 2025 and 2035. Point of Care Testing (POCT) refers to diagnostic test devices that are carried out either at or very near the point of patient care, allowing for immediate clinical decisions based on the results without having to send samples off to laboratory facilities. POCT offers a diverse range of portable and rapid test kits for glucose monitoring, infectious diseases, cardiac markers, etc. Such technology would be a meaningful enhancement to accessibility to health care, particularly in remote, disadvantaged communities. Growing demand for quick and accurate diagnosis has ensured that POCT is increasingly integral to emergency, ambulatory, and home health services. The industry is now witnessing strong momentum due to the technological developments and miniaturization, and integration of devices with digital health tools. Further, an increased focus on preventive healthcare and early detection is pushing the POCT adoption trends ahead. As health systems worldwide call for efficiency and decentralization, one can expect the POCT market to see continued and significant growth.
Rise in Chronic and Infectious Diseases
The increasing affliction of chronic and infectious diseases globally is fundamentally driving the growth of the POCT market. As practitioners today demand relatively fast clinical decisions, point-of-care tests increase the immediacy of a diagnostic option. The efficiency of managing conditions like diabetes, cardiovascular disorders, and respiratory infections by POCT makes it attractive. Furthermore, the demand for quick diagnosis during outbreaks of infectious diseases has further stimulated adoption. Increasingly, health systems are integrating the POCT for early intervention. The aforementioned trends imply shorter patient waiting times with improved care delivery.
Lack of Standardization and Quality Control
One of the major problems that is often associated with POCT, even though it facilitates quick testing, is quality assurance and consistency. Different devices might provide different results, thereby leading to diagnostic discrepancies. Test reliability could be questioned with the absence of standardized protocols across healthcare facilities. Erroneous readings, on the other hand, could put clinical decisions at risk due to a lack of quality control. Such variability becomes a hindrance to ensuring deployment in sensitive clinical applications. Thus, the additional headaches of ensuring regulatory compliance add fuel to the fire.
An increase in the use of nursing facilities at home
There is a home healthcare revolution in POCT. Patients suffering from incessant ailments are taking on the task of looking after their health, creating a niche for easy-to-use diagnostic tools. POCT is a flexible solution to monitor health by saving patients from the hassle of frequent visits to hospitals. This is most advantageous for the elderly patients and those with restricted mobility. The emerging trend coincides with the global shift towards patient-oriented care paradigms. Home healthcare puts less load on hospitals and clinics, and the manufacturers are out to take advantage of this developing scenario by designing small, simple products for testing.
Segment Analysis
POCT has performed above samples such as blood, urine, saliva, and other miscellaneous samples (swabs, capillary fluids, etc.). Blood samples have been the most widely used type of sample coming from the hematobiochemistry library for a very broad set of tests. Urine has usually been one of the sample types preferred in POCT for pregnancy, drug screening, and urinary tract infection diagnostics. Saliva rises into prominence as a "non-invasive" sample type, particularly during infectious disease testing and hormone monitoring. Nasal and throat swabs popped fast during viral outbreaks for rapid antigen and molecular tests. By working with different sample types, POCT offers increased flexibility within different care settings as well as wider use among various patients. This way, POCT can be customized to a specific testing need or environment.
Types of technologies included in POCT are lateral flow assays, dipsticks, microfluidics, molecular diagnostics, and biosensors. Lateral flow assays have largely subsumed other technologies because they are cheaper and easier to operate and tend to favor rapid testing in resource-limited settings. Dipstick technology encompasses just about all urinalysis and our ability to obtain a very quick qualitative result for many analytes. Microfluidics is doing transformational work in POCT by enabling multiplex testing with small mass samples. Molecular diagnostics are very high in terms of accuracy and sensitivity, especially when it comes to nucleic acid amplification for infectious pathogens. Biosensors provide real-time data, which has recently been integrated into wearable devices. All these technologies present distinct advantages in their specific diagnostic applications. Hence, POCT will always evolve with technology to cope with changing clinical and patient needs.
Regional Analysis
North America is the frontrunner in the POCT market by superior healthcare infrastructure and high degrees of technological entrepreneurship. The regions are established with major players who have constituted long-term competitive leadership for the market of POCT by repeatedly launching new products. Government regulation and prime stimulus packages are being used by every player in the region to tap into early diagnostic interventions. As the region earnestly pushes for value connected to healthcare, POCTs are coming out as the best possible enabler for enhanced handiness in the same. Professional and home settings see continuous heavy acceptance for those instruments in North America. Increased demand is being fueled by growing awareness in conjunction with both NICHCIS 2014 and a growing geriatric population that creates more POCT-ready waiting schedules. Eventually, North America will still stand at the point of center in terms of innovation and implementation in the POCT space.
Competitive Landscape
The competitors in the point-of-care testing market are highly fragmented, following an admixture of global heavyweights and emerging ones in the vicinity. To this point in time, the leading leaders invested greatly in the direction of R&D to come up with a twist in the product, which could be quite large on the testing menu and technological pedestal to fulfill huge needs, bypassing almost all other competitors. Mergers, acquisitions, and strategic collaborations under the same roof, nothing unusual at all for these guys, trying to redefine their commitment in the international marketplace and aiming to establish perfect, technologically equipped structures. Further pressure continues to be exerted to integrate digital networks and AI at the pool into smart data form, whereby they can provide diagnosis percentages. Young entrepreneurs are working on recipient updates on designs of these devices that are portable and child-friendly so that they can be used at home or from a distance. Pricing and regulatory approvals would play active roles in determining market participation and expansion. The competing environment is quite unstable, being a mirror image of the dynamic opportunities the market itself can offer, while the users are moving amidst rapidly changing expectations.
Report Coverage:
By Product Type
- Infectious Diseases Testing
- Blood Glucose Monitoring
- Cardiac Testing, Coagulation Testing
- Fertility Testing
- Drug Abuse Testing
- Respiratory Testing
- Others
By Sample Type
- Blood Samples
- Respiratory Samples
- Urine Samples
- Saliva Samples
- Fecal Samples
- Tissue Samples
- Other
By Technology
- Immunoassays
- Molecular Diagnostics
- Electrochemical Detection
- Optical Detection
- Bio Sensors
- Microfluidics
- Imaging Technology
- Wearable Technology
- Others

ページTOPに戻る

Table of Contents

Table of Contents
1. Methodology & Report Coverage
1.1. Definition & Objective
1.2. Market Evaluation & forecast parameter
1.3. Research Methodology
1.4. Data Validation Sources
1.4.1. Secondary Research
1.4.2. Primary Research
2. Market Overview
3. Global Point of Care Testing Market: Market Dynamics
3.1. Executive Summary
3.2. Market Driving Factors
3.2.1. Need for rapid diagnostic results to facilitate timely medical decisions and patient management
3.2.2. Technological innovations in POCT devices, including miniaturization, automation, and integration with digital platforms.
3.2.3. The increasing prevalence of chronic diseases such as diabetes, cardiovascular diseases, and infectious diseases
3.3. Key industry pitfalls & challenges
3.3.1. Ensuring the accuracy, reliability, and quality control of POCT devices can be challenging
3.3.2. Stringent regulatory requirements and approval processes for POCT devices across different regions
3.3.3. The initial cost of POCT devices and consumables, ongoing maintenance expenses
3.4. Market Opportunities
3.4.1. Rising disease burden in emerging markets
3.4.2. Integrating POCT devices with telemedicine platforms and remote monitoring solutions
3.4.3. Expanding the use of POCT devices beyond traditional healthcare settings to pharmacies, community health centers, workplaces
3.5. Porter’s Five Forces Analysis
3.6. PESTLE Analysis
3.7. Regulatory landscape
3.8. Pipeline Analysis
3.9. ESG Scenario
3.10. Competitive landscape
3.10.1. Company Market Share
3.10.2. Market Positioning
3.10.3. Strategy framework
3.10.4. Recent Acquisitions & Mergers
4. Point of Care Testing Market, Product Segment Analysis
4.1. Overview Dynamics
4.1.1. Market Revenue Share, By Product, 2025 & 2035
4.1.2. Key Market Trends, Growth Factors, & Opportunities
4.2. Infectious Diseases Testing
4.2.1. Market Revenue Share, By Product, 2025 & 2035
4.3. Blood Glucose Monitoring
4.3.1. Market Revenue Share, By Product, 2025 & 2035
4.4. Cardiac Testing
4.4.1. Market Revenue Share, By Product, 2025 & 2035
4.5. Coagulation Testing
4.5.1. Market Revenue Share, By Product, 2025 & 2035
4.6. Fertility Testing
4.6.1. Market Revenue Share, By Product, 2025 & 2035
4.7. Drug Abuse Testing
4.7.1. Market Revenue Share, By Product, 2025 & 2035
4.8. Respiratory Testing
4.8.1. Market Revenue Share, By Product, 2025 & 2035
4.9. Others
4.9.1. Market Revenue Share, By Product, 2025 & 2035
5. Point of Care Testing Market, Sample Type Segment Analysis
5.1. Overview
5.1.1. Market Revenue Share, By Sample Type, 2025 & 2035
5.1.2. Key Market Trends, Growth Factors, & Opportunities
5.2. Blood Samples
5.2.1. Market Size and Forecast, By Sample Type, 2025-2035 (USD Million)
5.3. Respiratory Samples
5.3.1. Market Size and Forecast, By Sample Type, 2025-2035 (USD Million)
5.4. Urine Samples
5.4.1. Market Size and Forecast, By Sample Type, 2025-2035 (USD Million)
5.5. Saliva Samples
5.5.1. Market Size and Forecast, By Sample Type, 2025-2035 (USD Million)
5.6. Fecal Samples
5.6.1. Market Size and Forecast, By Sample Type, 2025-2035 (USD Million)
5.7. Tissue Samples
5.7.1. Market Size and Forecast, By Sample Type, 2025-2035 (USD Million)
5.8. Others
5.8.1. Market Size and Forecast, By Sample Type, 2025-2035 (USD Million)
6. Point of Care Testing Market, Technology Segment Analysis
6.1. Overview
6.1.1. Market Revenue Share, By Technology, 2025 & 2035
6.1.2. Key Market Trends, Growth Factors, & Opportunities
6.2. Immunoassays
6.2.1. Market Size and Forecast, By Technology, 2025-2035 (USD Million)
6.3. Molecular Diagnostics
6.3.1. Market Size and Forecast, By Technology, 2025-2035 (USD Million)
6.4. Electrochemical Detection
6.4.1. Market Size and Forecast, By Technology, 2025-2035 (USD Million)
6.5. Optical Detection
6.5.1. Market Size and Forecast, By Technology, 2025-2035 (USD Million)
6.6. Bio Sensors
6.6.1. Market Size and Forecast, By Technology, 2025-2035 (USD Million)
6.7. Microfluidics
6.7.1. Market Size and Forecast, By Technology, 2025-2035 (USD Million)
6.8. Imaging Technology
6.8.1. Market Size and Forecast, By Technology, 2025-2035 (USD Million)
6.9. Wearable Technology
6.9.1. Market Size and Forecast, By Technology, 2025-2035 (USD Million)
6.10. Others
6.10.1. Market Size and Forecast, By Technology, 2025-2035 (USD Million)
7. Point of Care Testing Market, Region Segment Analysis
7.1. Overview
7.1.1. Global Market Revenue Share, By Region, 2025 & 2035
7.1.2. Global Market Revenue, By Region, 2025-2035 (USD Billion)
7.2. North America
7.2.1. North America Market Revenue, By Country, 2025-2035 (USD Billion)
7.2.2. North America Market Revenue, By Product, 2025-2035
7.2.3. North America Market Revenue, By Sample Type, 2025-2035
7.2.4. North America Market Revenue, By Technology, 2025-2035
7.2.5. The U.S.
7.2.5.1. U.S. Market Revenue, By Product, 2025-2035
7.2.5.2. U.S. Market Revenue, By Sample Type, 2025-2035
7.2.5.3. U.S. Market Revenue, By Technology, 2025-2035
7.2.6. Canada
7.2.6.1. Canada Market Revenue, By Product, 2025-2035
7.2.6.2. Canada Market Revenue, By Sample Type, 2025-2035
7.2.6.3. Canada Market Revenue, By Technology, 2025-2035
7.3. Europe
7.3.1. Europe Market Revenue, By Country, 2025-2035 (USD Billion)
7.3.2. Europe Market Revenue, By Product, 2025-2035
7.3.3. Europe Market Revenue, By Sample Type, 2025-2035
7.3.4. Europe Market Revenue, By Technology, 2025-2035
7.3.5. Germany
7.3.5.1. Germany Market Revenue, By Product, 2025-2035
7.3.5.2. Germany Market Revenue, By Sample Type, 2025-2035
7.3.5.3. Germany Market Revenue, By Technology, 2025-2035
7.3.6. France
7.3.6.1. Germany Market Revenue, By Product, 2025-2035
7.3.6.2. Germany Market Revenue, By Sample Type, 2025-2035
7.3.6.3. Germany Market Revenue, By Technology, 2025-2035
7.3.7. U.K.
7.3.7.1. Germany Market Revenue, By Product, 2025-2035
7.3.7.2. Germany Market Revenue, By Sample Type, 2025-2035
7.3.7.3. Germany Market Revenue, By Technology, 2025-2035
7.3.8. Italy
7.3.8.1. Germany Market Revenue, By Product, 2025-2035
7.3.8.2. Germany Market Revenue, By Sample Type, 2025-2035
7.3.8.3. Germany Market Revenue, By Technology, 2025-2035
7.3.9. Spain
7.3.9.1. Germany Market Revenue, By Product, 2025-2035
7.3.9.2. Germany Market Revenue, By Sample Type, 2025-2035
7.3.9.3. Germany Market Revenue, By Technology, 2025-2035
7.3.10. Rest of Europe
7.3.10.1. Germany Market Revenue, By Product, 2025-2035
7.3.10.2. Germany Market Revenue, By Sample Type, 2025-2035
7.3.10.3. Germany Market Revenue, By Technology, 2025-2035
7.4. Asia Pacific
7.4.1. Asia Pacific Market Revenue, By Country, 2025-2035 (USD Billion)
7.4.2. Asia Pacific Market Revenue, By Product, 2025-2035
7.4.3. Asia Pacific Market Revenue, By Sample Type, 2025-2035
7.4.4. Asia Pacific Market Revenue, By Technology, 2025-2035
7.4.5. China
7.4.5.1. China Market Revenue, By Product, 2025-2035
7.4.5.2. China Market Revenue, By Sample Type, 2025-2035
7.4.5.3. Canada Market Revenue, By Technology, 2025-2035
7.4.6. Japan
7.4.6.1. Japan Market Revenue, By Product, 2025-2035
7.4.6.2. Japan Market Revenue, By Sample Type, 2025-2035
7.4.6.3. Japan Market Revenue, By Technology, 2025-2035
7.4.7. India
7.4.7.1. India Market Revenue, By Product, 2025-2035
7.4.7.2. India Pacific Market Revenue, By Sample Type, 2025-2035
7.4.7.3. India Pacific Market Revenue, By Technology, 2025-2035
7.4.8. Australia
7.4.8.1. Australia Market Revenue, By Product, 2025-2035
7.4.8.2. Australia Pacific Market Revenue, By Sample Type, 2025-2035
7.4.8.3. Australia Pacific Market Revenue, By Technology, 2025-2035
7.4.9. South Korea
7.4.9.1. South Korea Market Revenue, By Product, 2025-2035
7.4.9.2. South Korea Market Revenue, By Sample Type, 2025-2035
7.4.9.3. South Korea Market Revenue, By Technology, 2025-2035
7.4.10. Singapore
7.4.10.1. Singapore Market Revenue, By Product, 2025-2035
7.4.10.2. Singapore Market Revenue, By Sample Type, 2025-2035
7.4.10.3. Singapore Market Revenue, By Technology, 2025-2035
7.4.11. Rest of Asia Pacific
7.4.11.1. Rest of Asia Pacific Market Revenue, By Product, 2025-2035
7.4.11.2. Rest of Asia Pacific Market Revenue, By Sample Type, 2025-2035
7.4.11.3. Rest of Asia Pacific Market Revenue, By Technology, 2025-2035
7.5. Latin America
7.5.1. Latin America Market Revenue, By Country, 2025-2035 (USD Billion)
7.5.2. Latin America Market Revenue, By Product, 2025-2035
7.5.3. Latin America Market Revenue, By Sample Type, 2025-2035
7.5.4. Latin America Market Revenue, By Technology, 2025-2035
7.5.5. Brazil
7.5.5.1. Brazil Market Revenue, By Product, 2025-2035
7.5.5.2. Brazil Market Revenue, By Sample Type, 2025-2035
7.5.5.3. Brazil Market Revenue, By Technology, 2025-2035
7.5.6. Argentina
7.5.6.1. Argentina Market Revenue, By Product, 2025-2035
7.5.6.2. Argentina Market Revenue, By Sample Type, 2025-2035
7.5.6.3. Argentina Market Revenue, By Technology, 2025-2035
7.5.7. Mexico
7.5.7.1. Mexico Market Revenue, By Product, 2025-2035
7.5.7.2. Mexico Market Revenue, By Sample Type, 2025-2035
7.5.7.3. Mexico Market Revenue, By Technology, 2025-2035
7.5.8. Rest of Latin America
7.5.8.1. Rest of Latin America Market Revenue, By Product, 2025-2035
7.5.8.2. Rest of Latin America Market Revenue, By Sample Type, 2025-2035
7.5.8.3. Rest of Latin America Market Revenue, By Technology, 2025-2035
7.6. MEA
7.6.1. MEA Market Revenue, By Country, 2025-2035 (USD Billion)
7.6.2. MEA Market Revenue, By Product, 2025-2035
7.6.3. MEA Market Revenue, By Sample Type, 2025-2035
7.6.4. MEA Market Revenue, By Technology, 2025-2035
7.6.5. GCC Countries
7.6.5.1. GCC Countries Market Revenue, By Product, 2025-2035
7.6.5.2. GCC Countries Market Revenue, By Sample Type, 2025-2035
7.6.5.3. GCC Countries Market Revenue, By Technology, 2025-2035
7.6.6. South Africa
7.6.6.1. South Africa Countries Market Revenue, By Product, 2025-2035
7.6.6.2. South Africa Countries Market Revenue, By Sample Type, 2025-2035
7.6.6.3. South Africa Countries Market Revenue, By Technology, 2025-2035
7.6.7. Rest of Middle-East Africa
7.6.7.1. Rest of Middle-East Africa Countries Market Revenue, By Product, 2025-2035
7.6.7.2. Rest of Middle-East Africa Countries Market Revenue, By Sample Type, 2025-2035
7.6.7.3. Rest of Middle-East Africa Countries Market Revenue, By Technology, 2025-2035
8. Company Profile
8.1. F. Hoffmann-La Roche Ltd.
8.1.1. Business Overview
8.1.2. Financial Performance
8.1.3. Product/Service Offerings
8.1.4. Strategies & recent developments
8.1.5. SWOT Analysis
8.2. Abbott Laboratories
8.2.1. Business Overview
8.2.2. Financial Performance
8.2.3. Product/Service Offerings
8.2.4. Strategies & recent developments
8.2.5. SWOT Analysis
8.3. Becton, Dickinson and Company (BD)
8.3.1. Business Overview
8.3.2. Financial Performance
8.3.3. Product/Service Offerings
8.3.4. Strategies & recent developments
8.3.5. SWOT Analysis
8.4. Danaher Corporation
8.4.1. Business Overview
8.4.2. Financial Performance
8.4.3. Product/Service Offerings
8.4.4. Strategies & recent developments
8.4.5. SWOT Analysis
8.5. Siemens Healthineers
8.5.1. Business Overview
8.5.2. Financial Performance
8.5.3. Product/Service Offerings
8.5.4. Strategies & recent developments
8.5.5. SWOT Analysis
8.6. Bio-Rad Laboratories Inc.
8.6.1. Business Overview
8.6.2. Financial Performance
8.6.3. Product/Service Offerings
8.6.4. Strategies & recent developments
8.6.5. SWOT Analysis
8.7. bioMérieux
8.7.1. Business Overview
8.7.2. Financial Performance
8.7.3. Product/Service Offerings
8.7.4. Strategies & recent developments
8.7.5. SWOT Analysis
8.8. Nova Biomedical
8.8.1. Business Overview
8.8.2. Financial Performance
8.8.3. Product/Service Offerings
8.8.4. Strategies & recent developments
8.8.5. SWOT Analysis
8.9. QuidelOrtho Corporation
8.9.1. Business Overview
8.9.2. Financial Performance
8.9.3. Product/Service Offerings
8.9.4. Strategies & recent developments
8.9.5. SWOT Analysis
8.10. Trinity Biotech
8.10.1. Business Overview
8.10.2. Financial Performance
8.10.3. Product/Service Offerings
8.10.4. Strategies & recent developments
8.10.5. SWOT Analysis
8.11. Sekisui Diagnostics
8.11.1. Business Overview
8.11.2. Financial Performance
8.11.3. Product/Service Offerings
8.11.4. Strategies & recent developments
8.11.5. SWOT Analysis
8.12. AccuBioTech Co., Ltd.
8.12.1. Business Overview
8.12.2. Financial Performance
8.12.3. Product/Service Offerings
8.12.4. Strategies & recent developments
8.12.5. SWOT Analysis
8.13. HemoCue AB (Danaher Corporation)
8.13.1. Business Overview
8.13.2. Financial Performance
8.13.3. Product/Service Offerings
8.13.4. Strategies & recent developments
8.13.5. SWOT Analysis
8.14. OraSure Technologies, Inc.
8.14.1. Business Overview
8.14.2. Financial Performance
8.14.3. Product/Service Offerings
8.14.4. Strategies & recent developments
8.14.5. SWOT Analysis
8.15. EKF Diagnostics Holdings plc.
8.15.1. Business Overview
8.15.2. Financial Performance
8.15.3. Product/Service Offerings
8.15.4. Strategies & recent developments
8.15.5. SWOT Analysis
8.16. Chembio Diagnostic Systems
8.16.1. Business Overview
8.16.2. Financial Performance
8.16.3. Product/Service Offerings
8.16.4. Strategies & recent developments
8.16.5. SWOT Analysis
8.17. Poc Diagnostics
8.17.1. Business Overview
8.17.2. Financial Performance
8.17.3. Product/Service Offerings
8.17.4. Strategies & recent developments
8.17.5. SWOT Analysis
8.18. Sysmex Corporation
8.18.1. Business Overview
8.18.2. Financial Performance
8.18.3. Product/Service Offerings
8.18.4. Strategies & recent developments
8.18.5. SWOT Analysis
8.19. BioLytical Laboratories Inc.
8.19.1. Business Overview
8.19.2. Financial Performance
8.19.3. Product/Service Offerings
8.19.4. Strategies & recent developments
8.19.5. SWOT Analysis
8.20. Meridian Bioscience
8.20.1. Business Overview
8.20.2. Financial Performance
8.20.3. Product/Service Offerings
8.20.4. Strategies & recent developments
8.20.5. SWOT Analysis

ページTOPに戻る

List of Tables/Graphs

Tables
TABLE 1. GLOBAL POINT OF CARE TESTING MARKET VALUE, BY SAMPLE TYPE, 2022-2028 (USD BILLION)
TABLE 2. GLOBAL POINT OF CARE TESTING MARKET VALUE FOR ACTIVATED CARBON, BY GEOGRAPHY, 2022-2028 (USD BILLION)
TABLE 3. GLOBAL POINT OF CARE TESTING MARKET VALUE FOR CARBON DERIVATIVES, BY GEOGRAPHY, 2022-2028 (USD BILLION)
TABLE 4. GLOBAL POINT OF CARE TESTING MARKET VALUE FOR METAL OXIDES, BY GEOGRAPHY, 2022-2028 (USD BILLION)
TABLE 5. GLOBAL POINT OF CARE TESTING MARKET VALUE FOR CONDUCTIVE POLYMERS, BY GEOGRAPHY, 2022-2028 (USD BILLION)
TABLE 6. GLOBAL POINT OF CARE TESTING MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2022-2028 (USD BILLION)
TABLE 7. GLOBAL POINT OF CARE TESTING MARKET VALUE, BY TECHNOLOGY, 2022-2028 (USD BILLION)
TABLE 8. GLOBAL POINT OF CARE TESTING MARKET VALUE FOR CONSUMER ELECTRONICS, 2022-2028 (USD BILLION)
TABLE 9. GLOBAL POINT OF CARE TESTING MARKET VALUE FOR INDUSTRIAL, BY GEOGRAPHY, 2022-2028 (USD BILLION)
TABLE 10. GLOBAL POINT OF CARE TESTING MARKET VALUE FOR TRANSPORTATION, BY GEOGRAPHY, 2022-2028 (USD BILLION)
TABLE 11. GLOBAL POINT OF CARE TESTING MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2022-2028 (USD BILLION)
TABLE 12. NORTH AMERICA POINT OF CARE TESTING MARKET VALUE, BY COUNTRY, 2022-2028 (USD BILLION)
TABLE 13. NORTH AMERICA POINT OF CARE TESTING MARKET VALUE, BY SAMPLE TYPE, 2022-2028 (USD BILLION)
TABLE 14. NORTH AMERICA POINT OF CARE TESTING MARKET VALUE, BY TECHNOLOGY, 2022-2028 (USD BILLION)
TABLE 15. U.S POINT OF CARE TESTING MARKET VALUE, BY SAMPLE TYPE, 2022-2028 (USD BILLION)
TABLE 16. U.S POINT OF CARE TESTING MARKET VALUE, BY TECHNOLOGY, 2022-2028 (USD BILLION)
TABLE 17. CANADA POINT OF CARE TESTING MARKET VALUE, BY SAMPLE TYPE, 2022-2028 (USD BILLION)
TABLE 18. CANADA POINT OF CARE TESTING MARKET VALUE, BY TECHNOLOGY, 2022-2028 (USD BILLION)
TABLE 19. EUROPE POINT OF CARE TESTING MARKET VALUE, BY COUNTRY, 2022-2028 (USD BILLION)
TABLE 20. EUROPE POINT OF CARE TESTING MARKET VALUE, BY SAMPLE TYPE, 2022-2028 (USD BILLION)
TABLE 21. EUROPE POINT OF CARE TESTING MARKET VALUE, TECHNOLOGY, 2022-2028 (USD BILLION)
TABLE 22. GERMANY POINT OF CARE TESTING MARKET VALUE, BY SAMPLE TYPE, 2022-2028 (USD BILLION)
TABLE 23. GERMANY POINT OF CARE TESTING MARKET VALUE, BY TECHNOLOGY, 2022-2028 (USD BILLION)
TABLE 24. U.K POINT OF CARE TESTING MARKET VALUE, BY SAMPLE TYPE, 2022-2028 (USD BILLION)
TABLE 25. U.K POINT OF CARE TESTING MARKET VALUE, BY TECHNOLOGY, 2022-2028 (USD BILLION)
TABLE 26. FRANCE POINT OF CARE TESTING MARKET VALUE, BY SAMPLE TYPE, 2022-2028 (USD BILLION)
TABLE 27. FRANCE POINT OF CARE TESTING MARKET VALUE, BY TECHNOLOGY, 2022-2028 (USD BILLION)
TABLE 28. ITALY POINT OF CARE TESTING MARKET VALUE, BY SAMPLE TYPE, 2022-2028 (USD BILLION)
TABLE 29. ITALY POINT OF CARE TESTING MARKET VALUE, BY TECHNOLOGY, 2022-2028 (USD BILLION)
TABLE 30. SPAIN POINT OF CARE TESTING MARKET VALUE, BY SAMPLE TYPE, 2022-2028 (USD BILLION)
TABLE 31. SPAIN POINT OF CARE TESTING MARKET VALUE, BY TECHNOLOGY, 2022-2028 (USD BILLION)
TABLE 32. ROE POINT OF CARE TESTING MARKET VALUE, BY SAMPLE TYPE, 2022-2028 (USD BILLION)
TABLE 33. ROE POINT OF CARE TESTING MARKET VALUE, BY TECHNOLOGY, 2022-2028 (USD BILLION)
TABLE 34. ASIA PACIFC POINT OF CARE TESTING MARKET VALUE, BY COUNTRY, 2022-2028 (USD BILLION)
TABLE 35. ASIA PACIFC POINT OF CARE TESTING MARKET VALUE, BY SAMPLE TYPE, 2022-2028 (USD BILLION)
TABLE 36. ASIA PACIFC POINT OF CARE TESTING MARKET VALUE, BY TECHNOLOGY, 2022-2028 (USD BILLION)
TABLE 37. CHINA POINT OF CARE TESTING MARKET VALUE, BY SAMPLE TYPE, 2022-2028 (USD BILLION)
TABLE 38. CHINA POINT OF CARE TESTING MARKET VALUE, BY TECHNOLOGY, 2022-2028 (USD BILLION)
TABLE 39. INDIA POINT OF CARE TESTING MARKET VALUE, BY SAMPLE TYPE, 2022-2028 (USD BILLION)
TABLE 40. INDIA POINT OF CARE TESTING MARKET VALUE, BY TECHNOLOGY, 2022-2028 (USD BILLION)
TABLE 41. JAPAN POINT OF CARE TESTING MARKET VALUE, BY SAMPLE TYPE, 2022-2028 (USD BILLION)
TABLE 42. JAPAN POINT OF CARE TESTING MARKET VALUE, BY TECHNOLOGY, 2022-2028 (USD BILLION)
TABLE 43. REST OF APAC POINT OF CARE TESTING MARKET VALUE, BY SAMPLE TYPE, 2022-2028 (USD BILLION)
TABLE 44. REST OF APAC POINT OF CARE TESTING MARKET VALUE, BY TECHNOLOGY, 2022-2028 (USD BILLION)
TABLE 45. REST OF WORLD POINT OF CARE TESTING MARKET VALUE, BY SAMPLE TYPE, 2022-2028 (USD BILLION)
TABLE 46. REST OF WORLD POINT OF CARE TESTING MARKET VALUE, BY TECHNOLOGY, 2022-2028 (USD BILLION)
TABLE 47. CABOT(NORIT): FINANCIALS
TABLE 48. CABOT(NORIT): PRODUCTS & SERVICES
TABLE 49. CABOT(NORIT): RECENT DEVELOPMENTS
TABLE 50. KURARY CO. LTD: FINANCIALS
TABLE 51. KURARY CO. LTD: PRODUCTS & SERVICES
TABLE 52. KURARY CO. LTD: RECENT DEVELOPMENTS
TABLE 53. BAYER SAMPLESCIENCE AG: FINANCIALS
TABLE 54. BAYER SAMPLESCIENCE AG: PRODUCTS & SERVICES
TABLE 55. BAYER SAMPLESCIENCE AG: RECENT DEVELOPMENTS
TABLE 56. CALGON CARBON CORPORATION: FINANCIALS
TABLE 57. CALGON CARBON CORPORATION: PRODUCTS & SERVICES
TABLE 58. CALGON CARBON CORPORATION: RECENT DEVELOPMENTS
TABLE 59. CARBON NT&F: FINANCIALS
TABLE 60. CARBON NT&F: PRODUCTS & SERVICES
TABLE 61. CARBON NT&F: RECENT DEVELOPMENTS
TABLE 62. SHENZHEN NTP: FINANCIALS
TABLE 63. SHENZHEN NTP: PRODUCTS & SERVICES
TABLE 64. SHENZHEN NTP: RECENT DEVELOPMENTS
TABLE 65. CECA SA: FINANCIALS
TABLE 66. CECA SA: PRODUCTS & SERVICES
TABLE 67. CECA SA: RECENT DEVELOPMENTS
TABLE 68. CNANO TECHNOLOGY: FINANCIALS
TABLE 69. CNANO TECHNOLOGY: PRODUCTS & SERVICES
TABLE 70. CNANO TECHNOLOGY: RECENT DEVELOPMENTS
TABLE 71. DONAU CHEMIE GROUP: FINANCIALS
TABLE 72. DONAU CHEMIE GROUP: PRODUCTS & SERVICES
TABLE 73. DONAU CHEMIE GROUP: RECENT DEVELOPMENTS
TABLE 74. SHOWA DENKO: FINANCIALS
TABLE 75. SHOWA DENKO: PRODUCTS & SERVICES
TABLE 76. SHOWA DENKO: RECENT DEVELOPMENTS